Short answer · Medically reviewed summary · Last updated: 2026-05-08
Hemicrania continua is classified under the ICD-10-CM code G44.829 (Hemicrania continua, not intractable) or G44.821 (Hemicrania continua, intractable). In the older ICD-9-CM system, there was no specific code for hemicrania continua, so it was typically categorized under 339.89 (Other headache syndromes). How is Hemicrania Continua clinically defined? Hemicrania continua is a rare, strictly unilateral primary headache disorder characterized by a continuous, fluctuating pain.
1 people with Hemicrania Continua have shared their first-person experience on this question at DiseaseMaps.
Hemicrania continua is classified under the ICD-10-CM code G44.829 (Hemicrania continua, not intractable) or G44.821 (Hemicrania continua, intractable). In the older ICD-9-CM system, there was no specific code for hemicrania continua, so it was typically categorized under 339.89 (Other headache syndromes).
Hemicrania continua is a rare, strictly unilateral primary headache disorder characterized by a continuous, fluctuating pain. Unlike many other headaches, it is defined by its absolute responsiveness to the medication indomethacin. For those of us in the DiseaseMaps community, which currently includes 86 members living with this condition, understanding these classification codes is essential for insurance documentation and accessing specialized care.
Diagnosis requires a headache that has been present for more than three months, with exacerbations of moderate to severe intensity. Clinicians look for specific autonomic symptoms during these peaks to confirm a Hemicrania continua diagnosis. Key clinical features often include:
Because Hemicrania continua is an indomethacin-responsive headache, the diagnostic process often serves as a therapeutic trial. If a patient does not respond to a strict regimen of indomethacin, neurologists may explore alternative treatments such as topiramate, gabapentin, or nerve blocks. Proper coding of Hemicrania continua ensures that insurance providers recognize the necessity of these specific, often long-term, pharmacological interventions.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.